Dr Leearne Hinch is the CEO of BARD1 Life Sciences. Now, this company’s share price started in February at 60 cents and it popped up to $5.60, would you believe, an intra-day high of $5.60 on Monday, this week. Anyway, it’s back down to $3 bucks or so now, but it’s been discovered, it’s taken off and to be honest, the bloke who told me about this is Jim Maxwell, the cricket commentator, and he first started telling me about BD1 a few weeks ago and Muggins here didn’t buy any. Well, I should have and the question is, should we buy them now at $3 bucks? Possibly we should, because this is a remarkable Australian biotech success story.
See the article on Euureka report website
